Dou, H., Wang, R., Tavallaie, M., Xiao, T., Olszewska, M., Papapetrou, E. P., Tall, A. R., & Wang, N. (2024). Hematopoietic and eosinophil-specific LNK(SH2B3) deficiency promotes eosinophilia and arterial thrombosis. Blood, 143(17), 1758–1772. https://doi.org/10.1182/blood.2023021055

Muir, A. B., Bailey, D. D., & Mehta, P. (2024). Embracing Diversity, Equity, Inclusion, and Accessibility in Eosinophilic Gastrointestinal Diseases. Immunology and Allergy Clinics of North America, 44(2), 293–298. https://doi.org/10.1016/j.iac.2024.01.002

Chehade, M., McGowan, E. C., Wright, B. L., Muir, A. B., Klion, A. D., Furuta, G. T., Jensen, E. T., & Bailey, D. D. (2024). Barriers to Timely Diagnosis of Eosinophilic Gastrointestinal Diseases. The Journal of Allergy and Clinical Immunology: In Practice, 12(2), 302–308. https://doi.org/10.1016/j.jaip.2023.12.020

Chehade, M., Wright, B. L., Atkins, D., Aceves, S. S., Ackerman, S. J., Assa’ad, A. H., Bauer, M., Collins, M. H., Commins, S. P., Davis, C. M., Dellon, E. S., Doerfler, B., Gleich, G. J., Gupta, S. K., Hill, D. A., Jensen, E. T., Katzka, D., Kliewer, K., Kodroff, E., … Rothenberg, M. E. (2023). Breakthroughs in understanding and treating eosinophilic gastrointestinal diseases presented at the CEGIR/TIGERs Symposium at the 2022 American Academy of Allergy, Asthma & Immunology Meeting. Journal of Allergy and Clinical Immunology, 152(6), 1382–1393. https://doi.org/10.1016/j.jaci.2023.08.021

Dellon, E. S., Gonsalves, N., Abonia, J. P., Alexander, J. A., Arva, N. C., Atkins, D., Attwood, S. E., Auth, M. K. H., Bailey, D. D., Biederman, L., Blanchard, C., Bonis, P. A., Bose, P., Bredenoord, A. J., Chang, J. W., Chehade, M., Collins, M. H., Di Lorenzo, C., Dias, J. A., … Aceves, S. S. (2022). International Consensus Recommendations for Eosinophilic Gastrointestinal Disease Nomenclature. Clinical Gastroenterology and Hepatology, 20(11), 2474-2484.e3. https://doi.org/10.1016/j.cgh.2022.02.017

Droghini, H. R., Abonia, J. P., Collins, M. H., Milner, J. D., Lyons, J. J., Freeman, A. F., Mukkada, V. A., Risma, K. A., Rothenberg, M. E., & Schwartz, J. T. (2022). Targeted IL-4Rα blockade ameliorates refractory allergic eosinophilic inflammation in a patient with dysregulated TGF-β signaling due to ERBIN deficiency. The Journal of Allergy and Clinical Immunology: In Practice, 10(7), 1903–1906. https://doi.org/10.1016/j.jaip.2022.01.012